Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-19

Clinical Trial Update: Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole [Phase 1]

View source ↗

Summary

Completed Phase 1 study evaluating how drug-drug interactions affect the pharmacokinetics of voriconazole in patients with invasive aspergillosis. The trial pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VFEND (Voriconazole)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Invasive Aspergillosis | Phase 1 | Status: COMPLETED